Can-Fite – pharmaceutical daily

May 15, 2020 Off

Can-Fite working on a strong candidate for the potential treatment of COVID-19

CanFite is working on Piclidenoson’s anti-viral, anti-inflammatory, anti-rheumatic properties and excellent safety profile make it a strong candidate for the…

March 15, 2020 Off

How do pharmaceutical companies profit from COVID-19? (do they?)

By Dino Mustafić

How do pharmaceutical companies prophet from COVID-19? Do they make the profit?

September 23, 2019 Off

Can-Fite Presents New Data on the Treatment of Advanced Liver Cancer with Namodenoson at the ILCA Conference

By BusinessWire

International Liver Cancer Association (ILCA) is devoted exclusively to liver cancer research A Phase III study protocol for Namodenoson in…